NO960647L - Vasokonstriktive substituerte dihydropyranopyridiner - Google Patents

Vasokonstriktive substituerte dihydropyranopyridiner

Info

Publication number
NO960647L
NO960647L NO960647A NO960647A NO960647L NO 960647 L NO960647 L NO 960647L NO 960647 A NO960647 A NO 960647A NO 960647 A NO960647 A NO 960647A NO 960647 L NO960647 L NO 960647L
Authority
NO
Norway
Prior art keywords
6alkyl
hydrogen
pct
formula
radical
Prior art date
Application number
NO960647A
Other languages
English (en)
Other versions
NO960647D0 (no
NO315001B1 (no
Inventor
Guy Rosalia Eugene Van Lommen
Francisco Javi Fernandez-Gadea
Jose Ignacio Andres-Gil
Maria Enc Matesanz-Ballesteros
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO960647D0 publication Critical patent/NO960647D0/no
Publication of NO960647L publication Critical patent/NO960647L/no
Publication of NO315001B1 publication Critical patent/NO315001B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19960647A 1993-08-19 1996-02-19 Farmasöytisk aktive substituerte dihydropyranopyridiner samt fremgangsmåteved fremstilling derav, hvor dihydropytanopyridinene harvaskokonstriktive egenskaper NO315001B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93202440 1993-08-19
PCT/EP1994/002700 WO1995005381A1 (en) 1993-08-19 1994-08-12 Vasoconstrictive substituted dihydropyranopyridines

Publications (3)

Publication Number Publication Date
NO960647D0 NO960647D0 (no) 1996-02-19
NO960647L true NO960647L (no) 1996-02-19
NO315001B1 NO315001B1 (no) 2003-06-23

Family

ID=8214053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19960647A NO315001B1 (no) 1993-08-19 1996-02-19 Farmasöytisk aktive substituerte dihydropyranopyridiner samt fremgangsmåteved fremstilling derav, hvor dihydropytanopyridinene harvaskokonstriktive egenskaper

Country Status (27)

Country Link
US (1) US5691344A (no)
EP (1) EP0714395B1 (no)
JP (1) JP3650398B2 (no)
KR (1) KR100330697B1 (no)
CN (1) CN1051085C (no)
AT (1) ATE178330T1 (no)
AU (1) AU684819B2 (no)
BR (1) BR9407298A (no)
CA (1) CA2168022C (no)
CZ (1) CZ286645B6 (no)
DE (1) DE69417560T2 (no)
DK (1) DK0714395T3 (no)
ES (1) ES2132424T3 (no)
FI (1) FI113773B (no)
GR (1) GR3029924T3 (no)
HU (1) HU228673B1 (no)
IL (1) IL110688A (no)
MY (1) MY111419A (no)
NO (1) NO315001B1 (no)
NZ (1) NZ271383A (no)
PL (1) PL177516B1 (no)
RO (1) RO116729B1 (no)
RU (1) RU2135501C1 (no)
SI (1) SI0714395T1 (no)
SK (1) SK282108B6 (no)
WO (1) WO1995005381A1 (no)
ZA (1) ZA946268B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
DE19950647A1 (de) * 1999-10-21 2001-04-26 Merck Patent Gmbh Imidazolderivate als Phosphodiesterase VII-Hemmer
US6818659B2 (en) 2001-11-06 2004-11-16 Bristol-Myers Squibb Pharma, Inc. (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides
WO2018002319A1 (en) * 2016-07-01 2018-01-04 Janssen Sciences Ireland Uc Dihydropyranopyrimidines for the treatment of viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU403673A1 (ru) * 1971-10-05 1973-10-26 Авторы изобретени витель Способ получения 2-амино-4н-пирано
SU466228A1 (ru) * 1973-02-28 1975-04-05 Дальневосточный государственный университет Способ получени 2,4-дифенил-7,7диметилтетрагидропирано(4,3-в)пиперидина
SU943240A1 (ru) * 1980-05-28 1982-07-15 Пермский государственный фармацевтический институт Способ получени производных 10-окси-10н-пиридо [2,3- @ ХРОМЕНОВ
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
AU576868B2 (en) * 1984-06-11 1988-09-08 E.I. Du Pont De Nemours And Company Thiophene and pyridine sulfonamides
CH674984A5 (no) * 1987-05-16 1990-08-15 Sandoz Ag
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
US5250450A (en) * 1991-04-08 1993-10-05 Micron Technology, Inc. Insulated-gate vertical field-effect transistor with high current drive and minimum overlap capacitance
DE4120322A1 (de) * 1991-06-20 1992-12-24 Bayer Ag Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
AU684819B2 (en) 1998-01-08
ZA946268B (en) 1996-02-19
RU2135501C1 (ru) 1999-08-27
CN1051085C (zh) 2000-04-05
SK19496A3 (en) 1997-02-05
NZ271383A (en) 1997-05-26
KR100330697B1 (ko) 2002-10-04
WO1995005381A1 (en) 1995-02-23
CZ37396A3 (en) 1996-05-15
GR3029924T3 (en) 1999-07-30
IL110688A (en) 1998-10-30
DK0714395T3 (da) 1999-10-11
PL313080A1 (en) 1996-05-27
SK282108B6 (sk) 2001-11-06
CZ286645B6 (cs) 2000-05-17
DE69417560D1 (de) 1999-05-06
ATE178330T1 (de) 1999-04-15
HUT74676A (en) 1997-01-28
EP0714395A1 (en) 1996-06-05
EP0714395B1 (en) 1999-03-31
DE69417560T2 (de) 1999-11-11
HU228673B1 (en) 2013-05-28
FI113773B (fi) 2004-06-15
BR9407298A (pt) 1996-10-01
NO960647D0 (no) 1996-02-19
RO116729B1 (ro) 2001-05-30
JP3650398B2 (ja) 2005-05-18
CA2168022A1 (en) 1995-02-23
FI960721A0 (fi) 1996-02-16
MY111419A (en) 2000-04-29
FI960721A7 (fi) 1996-02-16
PL177516B1 (pl) 1999-12-31
AU7499594A (en) 1995-03-14
US5691344A (en) 1997-11-25
NO315001B1 (no) 2003-06-23
ES2132424T3 (es) 1999-08-16
CN1129943A (zh) 1996-08-28
IL110688A0 (en) 1994-11-11
HU9600374D0 (en) 1996-04-29
CA2168022C (en) 2006-11-21
JPH09501669A (ja) 1997-02-18
SI0714395T1 (en) 1999-08-31

Similar Documents

Publication Publication Date Title
ATE165091T1 (de) Gefässverengende substituierte aryloxyalkyldiamine
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
GB0206860D0 (en) Compounds
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
JO2321B1 (en) 4-phenyl-pyridine derivatives
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
DE69417560D1 (de) Gefässverengende subtituierte dihydropyranopyridine
DE69616825D1 (en) Triazolone als apolipoprotein-b synthese ihibitoren
MY113426A (en) Vasoconstrictive substituted 2, 3-dihydro-1, 4- dioxinopyridines
ES499912A1 (es) Procedimiento para la obtencion de derivados de amino-tia- diazolilo
NZ512891A (en) S-oxide lipid lowering compounds
CA2211889A1 (en) Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
ATE170848T1 (de) Oxazolidin verbindungen und ihre verwendung als arzneimittel
ES444384A1 (es) Procedimiento de preparacion de nuevas biguadinas.

Legal Events

Date Code Title Description
MK1K Patent expired